Abstract
The last few years have seen an explosive growth in research on E2F transcription factors. Originally characterized as cellular proteins that are critical for adenovirus gene expression and replication, E2Fs have come to be seen as central players in the control of the animal cell cycle. This view comes about largely as the result of the remarkable finding that E2Fs are stably bound and regulated by the pRB tumor suppressor protein. The direct connections between E2Fs and the cell cycle control machinery go far beyond the pRB:E2F association, however, and are now realized to comprise a network of interactions among members of the pRB, E2F, cyclin, and cyclin-dependent kinase (cdk) protein families.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Afshari CA, Nichols MA, Xiong Y, Mudryj M (1995) The p21 protein interacts with multiple E2F complexes during the cell cycle in normal human fibroblasts (submitted)
Arroyo M, Bagchi S, Raychaudhuri P (1993) Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol 13: 6537–6546
Bagchi S, Raychaudhuri P, Nevins JR (1990) Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62: 659–669
Bagchi S, Weinmann R, Raychaudhuri P (1991) The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063–1072
Bandara LR, La Thangue NB (1991) Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351: 494–497
Bandara LR, Adamczewski JP, Hunt T, La Thangue NB (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352: 249–251
Bandara LR, Lam EWF, Sorensen TS, Zamanian M, Girling R, La Thangue MB (1994) Dp-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7. EMBO J 13: 3104–3114
Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE (1994) Functional interactions within E1A protein complexes. Oncogene 9: 359–373
Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R (1994) E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8: 2680–2690
Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R (1995) Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev 9: 1340–1353
Bernards R, Shackleford GM, Gerber MR, Horowitz JM, Friend SH, Schartl M, Bogenmann E, Rapaport JM, McGee T, Dryja TP, Weinberg RA (1989) Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Natl Acad Sci USA 86: 6474–6478
Blake MC, Azizkhan JC (1989) Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol 9: 4994–5002
Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097–1105
Cao L, Faha B, Dembski M,L-HT, Harlow E, Dyson N (1992) Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176–179
Carlotti F, Crawford L (1993) Trans-activation of the adenovirus E2 promoter by human papillomavirus type 16 E7 is mediated by retinoblastoma-dependent and -independent pathways. J Gen Virol 74: 2479–2486
Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89: 4549–4593
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the pRB protein. Cell 65: 1053–1061
Chen P-L, Scully P, Shew J-Y, Wang JYJ, Lee W-H (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193–1198
Chittenden T, Livingston DM, Kaelin WG (1991) The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65: 1073–1082
Chittenden T, Livingston DM, DeCaprio JA (1993) Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol Cell Biol 13: 3975–3983
Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper ML, Berns A, to Riele H (1992) Requirement for a functional pRB-1 gene in murine development. Nature 359: 328–330
Claudio PP, Howard CM, Baldi A, Luca AD, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A (1994) p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556–5560
Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA (1993) Cell cycle—specific association of E2F with the p130 E1A binding protein. Genes Dev 7: 2392–2404
Cress WD, Johnson DG, Nevins JR (1993) A genetic analysis of the E2F1 gene distinguishes regulation by pRB, P107, and adenovirus E4. Mol Cell Biol 13: 6314–6325
Dalton S (1992) Cell cycle regulation of the human cdc2 gene. EMBO J 11: 1797–1804
DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang C-M, Livingston DM (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085–1095
DeCaprio JA, Furukawa Y, Achenbaum F, Griffin JD, Livingston DM (1992) The retinoblastomasusceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Acad Sci USA 89: 1795–1798
Devoto SH, Mudryj M, Pines J, Hunter T, Nevins JR (1992) A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 68: 167–176
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberrg RA (1993) Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499–511
Dulic V, Lees E, Reed SI (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958–1961
Durfee T, Becherer K, Chen P, Yeh S, Yang Y, Kilburn AE, Lee W, Elledge SJ (1993) The retino-blastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7: 555–569
Dynlacht BD, Brook A, Dembski M, Yenush L, Dyson N (1994a) DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc Natl Acad Sci USA 91: 6359–6363
Dynlacht BD, Flores O, Lees JA, Harlow E (1994b) Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev 8: 1772–1786
Dyson N, Guida P, Munger K, Harlow E (1992) Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66: 6893–6902
Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M, Helin K (1993) Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol 67: 7641–7647
Egan C, Bayley ST, Branton PE (1989) Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene 4: 383–388
Ewen ME, Xing Y, Lawrence JB, Livingston DM (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66: 1155–1164
Ewen ME, Faha B, Harlow E, Livingston D (1992) Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255: 85–87
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J-Y, Livingston DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487–497
Fagan R, Flint KJ, Jones N (1994) Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78: 799–811
Faha B, Ewen ME, Tsai L-H, Livingston DM, Harlow E (1992) Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255: 87–90
Faha B, Harlow E, Lees E (1993) The adenovirus E1A-associated kinase consists of cyclin e-p33cdk2 and cyclinA-p33cdk2. J Virol 67: 2456–2465
Fattaey AR, Harlow E, Hello K (1993a) Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 13: 7267–7277
Fattaey AR, Helin K, Dembski MS, Dyson N, Harlow E, Vuocolo GA, Hanobik MG, Haskell KM, Oliff A, Defeo-Jones D, Jones RE (1993b) Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 8: 3149–3156
Flemington EK, Speck SH, Kaelin WG (1993) E2F-1 mediated trans-activation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 90: 6914–6918
Fung Y, T’Ang A, Murphree AL, Zhang F, Qiu W, Wang S, Shi X, Lee L, Driscoll B, Wu K (1993) The pRB gene suppresses the growth of normal cells. Oncogene 8: 2659–2672
Ginsberg D, Vairo G, Chittenden T, Xiao Z, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM (1994) E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8: 2665–2679
Goodrich DW, Wang NP, Qian Y-W, Lee EY-HP, Lee WH (1991) The retinoblastoma gene product regulates progression through the G, phase of the cell cycle. Cell 67: 293–302
Gu W Schneider JW, Condorelli G, Kaushal S, Mandavi V, Nadal-Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cgcell commitment and differentiation. Cell 72: 309–324
Hagemeier C, Bannister AJ, Cook A, Kouzarides T (1993a) The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90: 1580–1584
Hagemeier C, Cook A, Kouzarides T (1993b) The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res 21: 4998–5004
Hamel PA, Gill RM, Phillips RA, Gallie BL (1992). Transcriptional repression of the E2-containing promoters EIIaE, c-myc and RBI by the product of the 861 gene. Mol Cell Biol 12: 3431–3438
Hannon GJ, Demetrick D, Beach D (1993) Isolation of the pRB-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7: 2378–2391
Harlow E, Whyte P, Franza BJ, Schley C (1986) Association of adenovirus early-region 1 A proteins with cellular polypeptides. Mol Cell Biol 6: 1579–1589
Hatakeyama M, Brill JA, Fink GR, Weinberg RA (1994) Collaboration of G, cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev 8: 1759–1771
Helin K, Harlow E (1994) Heterodimerization of the transcription factor E2F-1 and DP-1 is required for binding to the adenovirus E4(ORF6/7) protein. J Virol 68: 5027–5035
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337–350
Helin K, Harlow E, Fattaey AR (1993a) Inhibition of E2F-1 trans-activation by direct binding of the retinoblastoma protein. Mol Cell Biol 13: 6501–6508
Helin K, Wu C-L, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E (1993b) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 7: 1850–1861
Herrera RE, Tan VP, Williams BO, Weinberg RA, Jacks T (1995) Altered cell cycle kinetics and gene expression in Rb-deficient fibroblasts (submitted )
Herrmann C, Su L, Harlow E (1991) Adenovirus E1A is associated with a serine/threonine protein kinase. J Virol 65: 5848–5859
Hiebert SW (1993) Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13: 3384–3391
Hiebert SW, Lipp M, Nevins JR (1989) E1A-dependent trans-activation of the human myc promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 86: 3594–3598
Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR (1992) The interaction of pRB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6: 177–185
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993–1006
Hsiao K-M, McMahon SL, Farnham PJ (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8: 1526–1537
Huang S, Wang N, Tseng BY, Lee W-H, Lee EY-HP (1990) Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J 9: 1815–1822
Huang S, Shin E, Sheppard K, Chokroverty L, Shan B, Qian Y, Lee EY, Lee W (1992) The retinoblastoma region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences. DNA Cell Biol 11: 539–548
Hunter T, Pines J (1991) Cyclins and cancer. Cell 66: 1071–1074
Ikeda M, Nevins JR (1993) Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol 13: 7029–7035
Imai Y, Matsushima Y, Sugimura T, Terada M (1991) Purification and characterization of human papilloma virus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol 65: 4966–4972
Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC (1993) Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13: 7802–7812
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an pRB mutation in the mouse. Nature 359: 295–300
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an pRB mutation in the mouse. Nature 359: 295–300
Johnson GD, Ohtani K, Nevins JR (1994) Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8: 1514–1525
Kaelin WG, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM (1991) Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64: 521–532
Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Alchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364
Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent Kinase, CDK4. Genes Dev 7: 331–342
Kiyokawa H, Richon VM, Rifkind RA, Marks PA (1994) Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14: 7195–7203
Kovesdi I, Reichel R, Nevins JR (1986) Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45: 219–228
Kovesdi I, Reichel R, Nevins JR (1987) Role of an adenovirus E2 promoter binding factor in E1Amediated coordinate gene control. Proc Natl Acad Sci USA 84: 2180–2184
Krek W, Livingston DM, Shirodkar S (1993) Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262: 1557–1560
Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingston DM (1994) Negative Regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161–172
Lam EW, Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12: 2705–2713
Lam EW, Morris JDH, Davies R, Crook T, Watson RJ, Vousden KG (1994) HPV E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 13: 871–878
La Thangue NB, Rigby PWJ (1987) An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma cells. Cell 49: 507–513
La Thangue NB, Thimmappaya B, Rigby PWJ (1990) The embryonal carcinoma stem cell E1a-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res 18: 2929–2938
Lees E, Faha B, Dulic V, Reed SI, Harlow E (1992) Cyclin E/cdk2 and cyclin A/cdks kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6: 1874–1885
Lee EY, Chang C, Hu N, Wang Y, Lai C, Herrup K, Lee W, Bradley A (1992) Mice deficient for pRB are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294
Lees J, Saito M, Vidal M, Valentino M, Look T, Harlow E, Dyson N, Helin K (1993) The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13: 7813–7825
Lees LA, Buchkovich KJ, Marshak DR, Anderson CW, Harlow E (1991) The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J 10: 4279–4290
Lew DJ, Dulic V, Reed SI (1991) Isolation of three novel human cyclins by rescue of G, cyclin (Cln) function in yeast. Cell 66: 1197–1206
Li Y, Graham C, Lacy S, Duncan AMV, Whyte P (1993) The adenovirus DA-associated 130 kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366–2377
Li Y, Slansky JE, Myers DJ, Drinkwater NR, Kaelin WG, Farnham PJ (1994) Cloning, Chromosomal location, and characterization of mouse E2F-1. Mol Cell Biol 14: 1861–1869
Lin BT-Y, Gruenwald S, Morla AO, Lee W-H, Wang JYJ (1991) Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J 10: 857–864
Ludlow JW, DeCaprio JA, Huang C-M, Lee W-H, Paucha E, Livingston DM (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57–65
Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA (1990) The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60: 387–396
Melamed D, Tiefenbrun N, Yarden A, Kimchi A (1993) Interferons and Interleukin-6 suppress the DNA- binding activity of E2F in growth-sensitive hematopoietic cells. Mol Cell Biol 13: 5255–5265
Mihara K, Cao X-R, Yen A, Chandler S, Driscoll B, Murphree AL, Tang A, Fung Y-KT (1989) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300–1303
Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, Weinberg RA (1994) Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J 13: 118–127
Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR (1991) Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65: 1243–1253
Neuman E, Remington EK, Sellers WR, Kaelin WG (1994) Transcription of the E2F1 gene is rendered cell cycle-dependent by E2F DNA bindidng sites within its promoter. Mol Cell Biol 14: 6607–6615
Ohtani K, Nevins JR (1994) Functional properties of a Drosophila homologue of the E2F1 gene. Mol Cell Biol 14: 1603–1612
Pagano M, Draetta G, and Jansen-Durr P (1992a) Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255: 1144–1147
Pagano M, Durst M, Joswig S, Draetta G, Jansen-Durr P (1992b) Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16immortalized cells. Oncogene 7: 1681–1686
Partridge JF, La Thangue NB (1991) A developmentally regulated and tissue-dependent tran- scription factor complexes with the retinoblastoma gene product. EMBO J 10: 3819–3827
Peeper DS, Parker LL, Ewen ME, Toebes M, Hall FL, Xu M, Zantema A, van den Eb AJ, PiwnicaWorms H (1993) A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J 12: 1947–1954
Philpott A, Friend SH (1994) E2F and its developmental regulation in Xenopuslaevis. Mol Cell Biol 14: 5000–5009
Qian Y, Luckey C, Horton L, Esser M, Templeton DJ (1992) Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12: 5363–5372
Qian Y, Wang Y, Hollingsworth RE, Jones D, Ling N, Lee EY (1993) A retinoblastoma-binding protein related to a negative regulator of ras in yeast. Nature 364: 648–652
Qin X, Chittenden T, Livingston DM, Kaelin WG (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6: 953–964
Qin X, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin WG (1995) The transcription factor E2F-1 is a downstream target of pRB action. Mol Cell Biol 15: 742–755
Ray SK, Arroyo M, Bagchi S, Raychaudhuri P (1992) Identification of a 60-kilodalton Rb-binding protein, RBP60, that allow the Rb-E2F complex to bind DNA. Mol Cell Biol 12: 4327–4333
Raychaudhuri P, Bagchi S, Devoto SH, Kraus VB, Moran E, Nevins JR (1991) Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev 5: 1200–1211
Reed SI (1992) The role of p34 kinases in the G, to S phase transition. Annu Rev Cell Biol 8: 529–561
Reichel R, Kovesdi I, Nevins JR (1987) Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48: 501–506
Reichel RR (1992) Regulation of E2F/cyclin A-containing complex upon retinoic acid-induced differentiation of teratocarcinoma cells. Gene Exp 2: 259–271
Robbins PD, Horowitz JM, Mulligan RC (1990) Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 346: 668–671
Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352: 541–544
Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA (1995) E2F-4 and E2F-5, two novel members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92: 2403–2407
Savatier P, Huang S, Szekely L, Wiman KG, Samarut J (1994) Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9: 809–818
Schwarz JK, Devoto SH, Smith EJ, Chellappan SP, Jakoi L, Nevins JR (1993) Interactions of the p107 and pRB proteins with E2F during the cell proliferation response. EMBO J 12: 1013–1020
Shan B, Zhu X, Chen P-L, Durfee T, Yang Y, Sharp D, Lee W-H (1992) Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 12: 5620–5631
Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Morgan DM, Chittenden T (1992) The transcription factor E2F interacts with the retinoblastoma product and a o107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157–166
Slansky JE, Li Y, Kaelin WG, Farnham PJ (1993) A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol 13: 1610–1618
Smith EJ, Nevins JR (1995) The pRB-related 0107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol Cell Biol 15: 338–344
Szekely L, Jiang W-Q, Bulic-Jakus F, Rosen A, Ringertz N, Klein G, Wiman KG (1992) Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ 3: 149–156
Templeton D, Park SH, Lanier L, Weinberg RA (1991) Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci USA 88: 3033–3037
Thalmeier K, Synovzik H, Mertz R, Winnacker E-L, Lipp M (1989) Nuclear factor E2F mediates basic transcription and trans-activation by E1A of the human myc promoter. Genes Dev 3: 527–536
Thut CJ, Chen J, Klemm R, Tjian R (1995) p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267: 100–104
Vairo G, Livingston DM, Ginsberg D (1995) Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 9: 869–881
Wang C, Petryniak B, Thompson CB, Kaelin WG, Leiden JM (1993) Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330–1335 Weinberg RA (1995) The Rb protein and cell cycle control. Cell 81: 323–330
Weintraub SJ, Prater CA, Dean DC (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259–262
Weintraub SJ, Chow KNB, Luo RX, Zhang SH, He S, Dean DC (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812–815
Welch PJ, Wang JYJ (1993) A C-terminal protein binding domain in pRB regulates the nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779–790
Welch PJ, Wang JYJ (1995) Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev 9: 31–46
Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124–129
Whyte P, Williamson NM, Harlow E (1989) Cellular targets of transformation by the adenovirus E1A protein. Cell 56: 67–75
Wu EW, Clemens KE, Heck DV, Munger K (1993) The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67: 2402–2407
Xu M, Sheppard K, Peng C, Yee AS, Piwnica-Worms H (1994) Cyclin A/cdk2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14: 8420–8431
Yee S.-Y, Branton PE (1985) Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virol 147: 142–153
Zamanian M, La Thangue NB (1992) Adenovirus E1 a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 11: 2603–2610
Zamanian M, La Thangue NB (1993) Transcriptional repression by the pRB-related protein p107. Mol Biol Cell 4: 389–396
Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111–1125
Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111–1125
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cobrinik, D. (1996). Regulatory Interactions Among E2Fs and Cell Cycle Control Proteins. In: Farnham, P.J. (eds) Transcriptional Control of Cell Growth. Current Topics in Microbiology and Immunology, vol 208. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79910-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-79910-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79912-9
Online ISBN: 978-3-642-79910-5
eBook Packages: Springer Book Archive